Overview

Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy

Status:
Suspended
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This is a trial to determine whether giving a patient a tailored dose of voriconazole is safe and effective.
Phase:
Phase 2
Details
Lead Sponsor:
Brynn Chappell
Collaborator:
The Christie NHS Foundation Trust
Treatments:
Antifungal Agents
Miconazole
Voriconazole